公司概覽
業務類別 --
業務概覽 Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines,and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.
公司地址 1-8-1 Tatsuminishi, Ikuno-ku, Osaka, JPN, 544-8666
電話號碼 +81 667581231
傳真號碼 --
公司網頁 https://www.rohto.co.jp
員工數量 10898
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Yasunori Kawasaki Director and Chief Human Resources Officer -- 25/06/2025
Mr. Hidetoshi Segi Director, President and Chief Operating Officer -- 25/06/2025
Mr. Masaya Saito Director, Executive Vice President and Chief Financial Officer -- 25/06/2025
Mr. Shinichi Kunisaki Director, Executive Vice President and Chief Technical Officer -- 25/06/2025
Mr. Kunio Yamada Chairman of the Board and Chief Executive Officer -- 25/06/2025
Mr. Yoichi Honma Director and Chief Scientific Officer -- 25/06/2025
Ms. Masae Yamanaka Director and Chief Transformation Officer -- 25/06/2025
Ms. Noriko Suenobu Director and Executive Designer, Strategic Design Headquarters -- 25/06/2025
Ms. Yoko Fujimoto Managing Director -- 25/06/2025
 
董事會成員
董事會 職務 更新日期
Mr. Yasunori Kawasaki Director and Chief Human Resources Officer 25/06/2025
Mr. Hidetoshi Segi Director, President and Chief Operating Officer 25/06/2025
Ms. Eriko Hayashi Independent Director 25/06/2025
Ms. Haruka Mera Independent Director 25/06/2025
Mr. Masaya Saito Director, Executive Vice President and Chief Financial Officer 25/06/2025
Mr. Shinichi Kunisaki Director, Executive Vice President and Chief Technical Officer 25/06/2025
Mr. Kunio Yamada Chairman of the Board and Chief Executive Officer 25/06/2025
Mr. Yoichi Honma Director and Chief Scientific Officer 25/06/2025
Mr. Akie Iriyama Independent Director 25/06/2025
Ms. Masae Yamanaka Director and Chief Transformation Officer 25/06/2025
Ms. Maiko Katadae Independent Director 25/06/2025
Ms. Noriko Suenobu Director and Executive Designer, Strategic Design Headquarters 25/06/2025
Ms. Yoko Fujimoto Managing Director 25/06/2025
Mr. Shoichiro Iwata Independent Director 25/06/2025
 
所屬ETF (更新日期: 02/05/2026 04:46)
代號 名稱 佔比% 持有日期
WSMLiShares MSCI World Small-Cap ETF0.01%27/04/2026
DWMWisdomTree International Equity ETF0.005%28/04/2026
GSIDGoldman Sachs MarketBeta Intl Eq ETF0.004%29/04/2026
BKIEBNY Mellon International Equity ETF0.004%27/04/2026
JPXNiShares JPX-Nikkei 400 ETF0.003%24/04/2026
MFDXPIMCO RAFI Dyn Multi-Factor Intl Eq ETF0.003%22/04/2026
FLJHFranklin FTSE Japan Hedged ETF0.002%28/04/2026
GXUSGoldman Sachs MarketBeta(R) Ttl IntEqETF0.002%29/04/2026
DIMWisdomTree International MidCap Div ETF0.002%28/04/2026
TLTDFlexShares Mstar DevMks exUS FctTilt ETF0.002%28/04/2026
IQSINYLI Candriam International Equity ETF0.001%28/04/2026
DFISDimensional International Small Cap ETF0.001%27/04/2026
DEEFXtrackers FTSE Develop ex US Mulfact ETF0.0003%28/04/2026
DXIVDimensional International Vector Eq ETF0.0003%27/04/2026
WRNDNYLI Global Equity R&D Leaders ETF0.0001%28/04/2026
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%06/03/2026
HSCZiShares Currency Hdgd MSCI EAFE SmCp ETF<0.000001%03/03/2026
IMFLInvesco Intl Dev Dynmc Mltfctr ETF<0.000001%08/04/2026
PBDMInvesco PureBeta FTSE Dev ex-NrthAmr ETF<0.000001%08/06/2023
  1   2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.